Calcium and PTH: Parathyroid Disorders and Bone Metabolism | Part 1 | 鈣與骨 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

Calcium balance reflects coordinated exchanges between bone, kidney and intestine,
regulated principally by parathyroid hormone and active vitamin D.
Parathyroid hormone resorbs bone, retains calcium in the kidney,
excretes phosphate and activates vitamin D.
Active vitamin D absorbs both calcium and phosphate from the gut.
Calcitonin and FGF-23 pull the other way,
and every calcium disorder leaves the residue of this contest.
Because PTH and vitamin D both raise calcium
but move phosphate in opposite directions,
the phosphate is the second number to read.
High calcium with low phosphate points to parathyroid hormone;
high calcium with high phosphate tells a different story.

Primary hyperparathyroidism is a single adenoma in about 80 per cent of cases.
Its signature is high calcium, low phosphate and high chloride,
with a hyperchloraemic acidosis.
An inappropriately raised
or even normal PTH in the presence of hypercalcaemia confirms the diagnosis.
Outpatient hypercalcaemia is usually parathyroid; inpatient hypercalcaemia is usually malignancy.
Cancer raises calcium through PTH-related peptide, and the true PTH is suppressed.
Familial hypocalciuric hypercalcaemia mimics the adenoma,
but an inactivating CASR mutation keeps the urine calcium-to-creatinine clearance ratio below 0.01,
and it never needs surgery.
Chronic kidney disease drives secondary hyperparathyroidism with low or normal calcium
and high phosphate.

Once the glands become autonomous,
calcium flips upward and the disease is tertiary.

Calcium balance reflects coordinated exchanges between bone, kidney and intestine,
regulated principally by parathyroid hormone and active vitamin D.


The clinical picture is stones, bones, groans and psychiatric overtones.
Polyuria arises from calcium-induced nephrogenic diabetes insipidus,
bone pain from osteitis fibrosa cystica.
Hypercalcaemia depresses neuromuscular function, causing weakness, constipation, drowsiness and a short QTc.
Hypocalcaemia excites it, producing paraesthesia, tetany,
Chvostek and Trousseau signs and a long QTc.
Reversing these two directions is the commonest examination error.

Severe hypercalcaemia, above 3.5 mmol/L with symptoms, is an emergency,
and the treatment order is a chain of logic.
Dehydration lowers the filtration rate and traps calcium,
so intravenous saline restores volume and flushes calcium first.
Thiazides are absolutely contraindicated because they reduce urinary calcium excretion.
Loop diuretics are added only for overload.
Zoledronic acid treats the cause by suppressing osteoclasts,
but it takes two to four days.
Calcitonin acts within hours and fades within two days,
so it bridges the gap.
Denosumab serves refractory or renal cases, glucocorticoids treat lymphoma and granulomatous disease,
and dialysis rescues the failing kidney.

Hypocalcaemia is assessed in a fixed order.
Corrected calcium equals measured calcium plus 0.02 multiplied by 40 minus the
albumin in grams per litre.
Then PTH separates parathyroid failure from downstream causes.
Then magnesium is checked, because hypomagnesaemia suppresses PTH and blocks its action,
so calcium cannot be replaced until magnesium is.
Alkalosis binds calcium to albumin and lowers ionised calcium,
which is why hyperventilation causes tetany.
Osteoporosis is diagnosed at a T-score of minus 2.5 or below,
or clinically after a hip or vertebral fragility fracture.
Antiresorptives suppress osteoclasts, whereas intermittent teriparatide builds bone,
because continuous PTH erodes and pulsed PTH restores.

Calcium balance reflects coordinated exchanges between bone, kidney and intestine,
regulated principally by parathyroid hormone and active vitamin D.

Medical Notes · 醫學學習提示

  1. 鈣平衡由骨、腎與腸道共同維持;圖為構造示意
  2. 副甲狀腺素與活性維生素 D 是主要調節者
  3. PTH 間接促進骨吸收,並增加腎臟保鈣
  4. PTH 促進腎排磷,並刺激活性維生素 D 生成
  5. 活性維生素 D 增加腸道對鈣與磷的吸收
  6. FGF23 促排磷並抑制活性 D;降鈣素抑制骨吸收
  7. 兩者作用並非完全相同,成人降鈣素調節作用較小
  8. PTH 與活性維生素 D 都可增加血鈣
  9. PTH 促排磷;活性 D 則增加腸道吸磷
  10. 血磷須合併 PTH、腎功能與維生素 D 判讀
  11. 高鈣低磷提示 PTH 或 PTHrP 作用,非單獨確診
  12. 高鈣高磷須另查維生素 D 與腎功能等原因
  13. 原發性副甲狀腺亢進多由單一腺瘤造成
  14. 常見高鈣、低磷;高氯不是必要診斷條件
  15. 高氯性酸中毒並非每例皆有,須另查其他原因
  16. 高鈣時 PTH 應受抑制
  17. PTH 未受抑制提示 PTH 依賴性;須排除 FHH 等
  18. 門診與住院病因分布不同,不能以場域確診
  19. 惡性腫瘤可經 PTHrP、溶骨或活性 D 致高鈣
  20. 家族性低尿鈣高血鈣症可類似原發性亢進
  21. CCCR 閾值是 0.01,非 0.1;低值仍有重疊
  22. FHH 通常不做副甲狀腺手術;須先確認診斷
  23. 慢性腎病可使 PTH 升高,血鈣偏低或正常
  24. 高磷多見較晚期;早期血磷仍可能正常
  25. 長期刺激後,副甲狀腺可能自主分泌
  26. PTH 與血鈣皆高可提示三發性亢進
  27. 骨與腎共同維持血鈣,腸道提供吸收來源
  28. 副甲狀腺位置可變;圖中峽部與周圍構造省略
  29. 高鈣可有結石、骨病、腹部與精神症狀
  30. 高鈣可降低腎臟對抗利尿激素的反應而多尿
  31. 嚴重副甲狀腺亢進可出現纖維囊性骨炎
  32. 高鈣常見無力、便祕、嗜睡與 QT 縮短
  33. 低鈣可致感覺異常、肌肉痙攣與搐搦
  34. 低鈣可延長 QT;體徵仍須結合抽血確認
  35. 記憶方向:高鈣抑制、低鈣增加神經肌肉興奮
  36. 血鈣超過 3.5 mmol/L 即須緊急評估,勿等症狀
  37. 治療需同時評估容量、心腎功能及病因
  38. 脫水降低腎臟清除鈣的能力
  39. 靜脈等張鹽水補充容量;心腎病須調整速度
  40. 高血鈣時通常停用噻嗪類,避免加重保鈣
  41. 袢利尿劑不常規降鈣,主要用於容量過多
  42. 唑來膦酸抑制骨吸收,不等於根治腫瘤病因
  43. 降鈣效應需數日,並須考量腎功能
  44. 降鈣素起效快;耐受性限制使用約 48–72 小時
  45. 可暫時銜接較慢起效的抗骨吸收治療
  46. Denosumab 依病因選用;重度腎病須防嚴重低鈣
  47. 難治高鈣或無法補液者,可由專科評估透析
  48. 低鈣急症先治療,同步查原因;不是僵化順序
  49. 校正公式僅估計;重症、酸鹼異常宜測游離鈣
  50. 公式單位:鈣 mmol/L、白蛋白 g/L;依實驗室校正
  51. 以 PTH 配合鈣、磷、腎功能與維生素 D 找原因
  52. 低鎂可抑制 PTH 分泌,並造成周邊作用阻抗
  53. 急症勿等補鎂才補鈣:監測下同步矯正
  54. 鹼血症增加白蛋白結合鈣,使游離鈣降低
  55. 過度換氣可致搐搦,仍須評估誘因與危險病因
  56. 停經女性與 50 歲以上男性:T 分數 ≤ −2.5
  57. 低創傷髖部或椎體骨折可支持臨床骨鬆診斷
  58. 抗骨吸收藥減少骨流失;間歇性 PTH 類藥促成骨
  59. 持續與間歇刺激不同;骨重塑仍受多因素調節
  60. 回顧骨、腎與腸道的鈣磷交換
  61. PTH 與活性維生素 D 協調鈣平衡

References